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OBJECTIVE—To investigate the basal insulin requirement in total daily insulin dose in Jap-
anese type 1 diabetic patients who use the insulin pump.
RESEARCH DESIGN AND METHODS—The basal insulin requirement in 35 type 1
diabetic patients without detectable C-peptide using the insulin pump (Paradigm 712) was
investigated during 2–3 weeks of hospitalization. The patients were served diabetic diets of
25–30 kcal/kg ideal body weight. Each meal omission was done to conﬁrm stable blood glu-
cose levels within 30 mg/dL variance until the next meal. Target blood glucose level was set at
100 mg/dL before each meal and 150 mg/dL at 2 h after each meal.
RESULTS—Total daily insulin dose was 31.6 6 8.5 units, and total basal insulin requirement
was 8.7 6 2.9 units, which was 27.7 6 6.9% of the total daily dose.
CONCLUSIONS—Basalinsulinrequirement is;30%of thetotaldaily dose inJapanesetype
1 diabetic patients who use the insulin pump.
Diabetes Care 34:1089–1090, 2011
I
nsulin therapy consists of basal insulin
to keep blood glucose level stable and
bolus insulin to control postprandial
hyperglycemia and to correct hypergly-
cemia if necessary. Type 1 diabetic pa-
tients who run out of their own insulin
secretion are recommended to set proper
amountsofbasalinsulin.Accordingtothe
textbook,total basalinsulindose (TBD) is
;50% of the total daily insulin dose
(TDD) (1–3).
The purpose of this study was to
assess basal insulin requirement in type 1
diabeticpatients,whoareoninsulinpump
therapy, without detectable C-peptide
(,0.1 ng/mL). This study was done dur-
ing 2–3 weeks of hospitalization in pa-
tients on diabetic diets.
RESEARCH DESIGN AND
METHODS—Among 42 Japanese pa-
tients treated with the insulin pump, 35
were consecutively selected who met the
inclusion and exclusion criteria and who
signed an informed consent. We used a
Paradigm 712 pump (Medtronic, North-
ridge, CA) with which we program basal
insulin infusion hourly every 0.05 units.
All patients used rapid-acting insulin in
their pumps and were asked to monitor
blood glucose four times daily. To ex-
clude factors that could modify insulin
dose requirements (2), the patients were
hospitalized in Osaka University Medical
Hospital from July 2007 to July 2010 to
adjust the insulin pump. We excluded indi-
viduals with eating disorders, concomitant
dietary restrictions, unstable retinopathy,
renal failure, or pregnancy or who were
usingotherantidiabeticagentsorsteroids.
During the 2–3 weeks of hospitalization,
an eight-point glucose testing (before and
2 h after each meal [2200 and 0300 h])
was performed to allow optimization of
basal insulin rates according to the previ-
ous report (4). The diabetic meals in all
studies were 25–30 kcal/kg ideal body
weight, consisting of 50–60% carbohy-
drate, 15–20% protein, and 20–25% fat
and were prepared by dietitians. Over-
night basal insulin rates were evaluated
with the blood glucose readings at 2200,
0300, and 0700 h and set using the same
method (4). Upon veriﬁcation of the basal
rates, bolus insulin was determined by
physicians using carbohydrate counting.
All meals were consumed within 20 min;
noadditionalfoodordrinkwasconsumed
unless required to treat hypoglycemia.
The target fasting glucose and 2-h post-
prandial glucose values were set at 100
and 150 mg/dL in each participant.
TDD, TBD, and percentage of TBD to
TDD (%TBD) were collected after achiev-
ing the target glucose level at least for
3 days. The average of the eight-point glu-
cosetestingfortheﬁnal3daysofthestudy
period was collected. HbA1c,T D D ,a n d
%TBD at 6 months after the study period
in26patientswerecollected.Demographic
data are presented as means 6 SD.
RESULTS—Characteristics of the study
subjects were as follows: sex, 11 males/
24 females; age, 39.7 6 10.9 years (20–
69) [mean 6 SD (range)]; body weight,
56.5 6 10.0 kg (36–80); BMI,22.06 3.0
kg/m
2 (14.6–28.7); duration of diabetes,
22.1 6 11.4 years (2–44); HbA1c,7 . 2 66
1.40% (5.0–11.5).
The average of the eight-point blood
glucose was shown in Fig. 1A (upper
panel). According to the meal omission,
basal insulin dose was adjusted in each
patient. Basal insulin rate was shown in
Fig. 1A (lower panel). TBD was 8.7 6 2.9
units(3.3–15.3),TDDwas31.668.5units
(18–50), and TDD/kg was 0.56 6 0.13
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BRIEF REPORTunits/kg(0.32–0.84).AsshowninFig.1B,
%TBD was 27.7 6 6.9% (16.6–43.8). No
patients required 50% TDD. In addition,
there was no relationship between BMI,
age, HbA1c, and %TBD (data not shown).
HbA1c changed from 7.42 6 1.32 to
6.95 6 1.46% (P , 0.01), TDD changed
from32.06 7.8to33.96 12.0 units/day
(P = 0.21), and %TBD changed from
28.9 6 5.1 to 29.7 6 6.2% (P = 0.54) at
6 months after the study period.
CONCLUSIONS—We investigated
here the basal insulin requirement in
C-peptide–negative type 1 diabetic pa-
tients. Our results show that basal insulin
requirement is ;30% TDD in the inpa-
tients on diabetic diets prepared by a die-
titian (Fig. 1B). In addition, the maximal
basal insulin requirement in all patients
was43.8%TDD,andnopatientsrequired
50% TDD. These results indicate the cur-
rently widely published formula (TBD =
0.53TDD)(1–3)overestimatestheTBD.
King (5) also recently suggested that this
should be revised to TBD = 0.4 3 TDD to
prevent excess basal insulin treatment.
In our results, TBD was ;30% TDD,
which was less than King’se s t i m a t i o n .
We assume that this is the result of the
strict diabetic diet in the hospital setting.
Diabetic meals are served to all patients.
These meals are close to the macronutrient
content as the meals recommended by the
American Diabetes Association (6).
We consider that previous estimation
(TBD = 0.5 3 TDD) might have been
inﬂuenced by several factors as follows.
One is diet failure, i.e., increased fat in-
take.Fatingestionmaycausedelayofgas-
tric emptying, leading to late glucose
excursion (7). When eating fat-rich pizza,
it was recommended to give dual-wave
bolus insulin for 8 h, which means giving
bolus insulin for 8 h after normal bolus
insulin to suppress late glucose excursion
induced by fat (8). The basal insulin re-
quirement in the daily life after discharge
might be more than in the hospital if pa-
tients eat more fat than recommended.
However, %TBD stayed at the same level
without deteriorating glucose control 6
months after the study period. The other
factor is the misunderstanding of blood
glucose monitoring data in well con-
trolled patients. There are some patients
who set their basal insulin higher than
required to lower their blood glucose.
In these patients, although the peak
glucose value is high, HbA1c is seem-
ingly well controlled, which leads to
the misunderstanding about their basal
requirement.
We did not use a continuous glucose
monitoring system (CGMS) in our study.
Although there is a report showing that
eight-point glucose testing a day is com-
parable to a continuous glucose monitor-
ing system, eight-point glucose testing
has the possibility of missing midnight
hypoglycemia (9). In such a case, it might
be better to further reduce the TBD. Fur-
thermore, this study is of small size and is
not designed to be a randomized study
comparing different percentages of basal
and bolus.
In conclusion, basal insulin require-
ment is ;30% TDD in Japanese type 1
diabetic patients who use the insulin
pump.
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Figure 1—A:Eight-point bloodglucoseproﬁleduringtheﬁnal3daysof hospitalizationintype1
diabetic patients using the insulin pump (upper panel). Basal insulin requirement (units/h)
(lower panel) is shown. Data are expressed as means 6 SD. B: Percentage of basal insulin
requirement in TDD. TBD was 27.7 6 6.9% TDD (n =3 5 ) .
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